porcin
reproduct
respiratori
syndrom
viru
prrsv
small
envelop
positivestrand
rna
viru
belong
famili
arterivirida
sinc
emerg
late
europ
north
america
caus
signific
econom
loss
pork
industri
worldwid
outbreak
hpprrsv
describ
pig
high
fever
diseas
occur
china
caus
disastr
lose
farmer
diseas
current
major
concern
swine
industri
worldwid
akt
key
signal
transduct
pathway
regul
cell
surviv
cell
prolifer
differenti
cell
apoptosi
activ
pathway
promot
cell
surviv
phosphoryl
numer
substrat
glycogen
synthas
bad
mtor
mani
virus
known
manipul
pathway
favor
replic
influenza
viru
hepat
b
viru
hepat
c
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
viru
human
immunodefici
viru
type
bovin
herpesviru
type
infecti
bursal
diseas
viru
previou
studi
shown
prrsv
infect
porcin
monocytederiv
dendrit
cell
modc
pathway
activ
min
h
postinfect
h
pi
inhibit
h
pi
vivo
viru
show
narrow
cell
tropism
infect
specif
subpopul
porcin
macrophag
vitro
effici
prrsv
replic
observ
primari
pig
macrophag
eg
alveolar
macrophag
differenti
monocyt
cell
deriv
african
green
monkey
kidney
easi
manipul
cell
provid
import
tool
studi
prrsv
replic
previous
report
pathway
regul
prrsv
complex
manner
modc
whether
univers
phenomenon
permiss
cell
unknown
number
studi
shown
signal
pathway
function
depend
downstream
substrat
akt
bad
mtor
regul
cell
surviv
downstream
target
akt
control
prrsv
identifi
object
studi
address
pathway
modul
infect
cell
pam
highli
pathogen
prrsv
demonstr
pathway
activ
hpprrsv
cellculturedepend
manner
downstream
target
bad
regul
pathway
addit
found
activ
requir
develop
cpe
cell
product
infecti
progeni
hpprrsv
strain
use
present
studi
isol
pig
show
sign
high
fever
syndrom
origin
swine
farm
region
hunan
provinc
china
stock
viru
passag
prepar
cell
titrat
store
use
cell
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
brl
supplement
fetal
bovin
serum
gibco
brl
incub
contain
pam
cultur
obtain
bronchoalveolar
lavag
domest
piglet
prrsvneg
herd
affili
shanghai
agricultur
scienc
institut
anim
experi
conduct
accord
guidelin
approv
protocol
shanghai
veterinari
research
institut
anim
care
committe
pam
cultur
medium
supplement
fetal
bovin
serum
experi
conduct
veterinari
laboratori
biosafeti
level
rabbit
monoclon
antibodi
mab
recogn
phosphoakt
phosphobad
phosphomtor
purchas
cell
signal
technolog
inc
mous
monoclon
antibodi
obtain
santa
cruz
biotechnolog
inc
santa
cruz
calif
horseradish
peroxidas
hrp
conjug
antirabbit
igg
antimous
igg
purchas
zhongshan
golden
bridg
biotechnolog
co
ltd
inhibitor
suppli
cell
signal
technolog
stock
inhibitor
prepar
dmso
cell
dish
grown
confluenc
whereupon
subject
serum
starvat
h
serumfre
dmem
subsequ
growtharrest
cell
infect
multipl
infect
moi
viru
mock
infect
medium
one
hour
postinfect
pi
cell
wash
phosphatebuff
salin
pb
ph
cultur
fresh
dmem
variou
time
indic
inhibitor
experi
cell
pretreat
inhibitor
h
cell
infect
viru
moi
h
wash
pb
place
serumfre
medium
contain
fresh
inhibitor
sustain
h
dmem
contain
dmso
vv
use
mock
treatment
unless
otherwis
specifi
growtharrest
pam
cell
cultur
dish
infect
moi
mock
infect
medium
incub
variou
time
indic
cell
collect
western
blot
analysi
inactiv
hpprrsv
uv
irradi
viru
stock
dispers
tissu
cultur
dish
place
directli
uv
lamp
w
min
complet
inactiv
viru
confirm
titrat
cell
cell
pam
expos
uvirradiationinactiv
viru
analyz
variat
phosphoryl
akt
within
h
pi
indic
hpprrsv
infect
length
time
indic
cell
wash
pb
lyse
lysi
buffer
triton
mm
sodium
chlorid
mm
edta
mm
egta
mm
sodium
fluorid
mm
sodium
pyrophosph
mm
phenylmethylsulfonyl
fluorid
leupeptin
mm
benzamidin
mm
sodium
orthovanad
mm
trishcl
ph
cell
lysat
clear
centrifug
min
prior
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
reduc
condit
separ
protein
transfer
onto
nitrocellulos
membran
millipor
membran
block
h
room
temperatur
skim
milk
solut
trisbuff
salin
contain
tween
blot
incub
overnight
primari
antibodi
follow
incub
h
secondari
antibodi
conjug
horseradish
peroxidas
extens
wash
immunoreact
band
detect
enhanc
chemiluminesc
ecl
pierc
subsequ
reprob
total
protein
load
use
antibodi
analyz
whether
inhibit
would
affect
viru
replic
serumstarv
cell
seed
plate
preincub
inhibitor
mock
pretreat
dmem
contain
dmso
h
infect
viru
h
togeth
without
inhibitor
extens
wash
pb
cell
place
dmem
without
fresh
inhibitor
h
two
round
freez
thaw
infecti
progeni
titrat
cell
use
assay
first
use
cell
model
examin
kinet
akt
phosphoryl
requir
akt
activ
determin
whether
hpprrsv
infect
modul
pathway
cell
mock
infect
dmem
medium
infect
hpprrsv
strain
harvest
min
min
min
min
h
h
h
h
h
h
postinfect
western
blot
analysi
found
akt
activ
biphas
manner
infect
cell
hpprrsv
fig
top
panel
first
phase
akt
activ
occur
earli
min
pi
viru
infect
fig
h
pi
phosphoryl
akt
return
basal
level
certain
interv
akt
phosporyl
increas
late
stage
infect
amount
phosphoryl
akt
evid
increas
h
pi
level
sustain
remind
investig
h
pi
fig
upper
panel
chang
akt
phosphoryl
due
variat
total
amount
protein
load
fig
bottom
panel
sinc
akt
activ
pathway
role
activ
virusinduc
akt
activ
subsequ
investig
chemic
potent
specif
inhibitor
use
demonstr
immunoblot
assay
could
effici
inhibit
phosporyl
akt
induc
viru
late
stage
infect
fig
indic
activ
account
virustrigg
akt
activ
taken
togeth
data
indic
pathway
activ
infect
cell
prrsv
sinc
pam
monocyt
major
natur
target
cell
acut
persist
prrsv
infect
deserv
investig
whether
viru
control
pathway
infect
pam
kinet
phosphoryl
akt
determin
hpprrsvinfect
pam
vitro
serumstarv
pam
mock
infect
medium
infect
min
min
min
min
h
h
h
h
h
h
postinfect
collect
western
blot
illustr
fig
amount
phosphoryl
akt
increas
dramat
min
pi
howev
activ
transient
quickli
return
basal
level
min
postinfect
addit
enhanc
phosphoryl
akt
observ
later
stage
suggest
akt
activ
hpprrsv
earli
phase
infect
pam
differ
observ
cell
sinc
increas
phosphoryl
akt
induc
hpprrsv
observ
min
min
postinfect
virusinfect
cell
min
postinfect
pam
hypothes
viru
entri
process
account
earlystag
activ
thu
uvirradi
hpprrsv
viru
employ
address
issu
condit
describ
viru
could
complet
inactiv
data
shown
inactiv
viru
fail
express
viral
protein
due
format
thymidin
dimer
prevent
transcript
viral
gene
interfer
capac
viru
receptor
bind
entri
host
cell
endocytosi
show
fig
exposur
cell
uvirradi
viru
led
phosphoryl
akt
min
postinfect
pam
fig
cell
fig
indic
viruscel
interact
bind
entri
process
probabl
respons
event
pam
wherea
cell
differ
mechan
may
account
activ
investig
mechan
hpprrsv
promot
cell
surviv
downstream
target
akt
late
stage
infect
cell
analyz
western
blot
use
rabbit
monoclon
antibodi
phosphobad
phosphomtor
compar
mockinfect
control
viru
replic
result
significantli
increas
phosphoryl
bad
chang
mtor
observ
fig
phosphoryl
bad
evid
h
pi
correspond
time
chang
phosphoryl
akt
address
whether
chang
phosphoryl
bad
induc
viru
pathway
inhibitor
employ
investig
shown
fig
treatment
cell
significantli
decreas
amount
phosphoryl
bad
induc
viru
replic
suggest
viru
manipul
activ
bad
pathway
sinc
pathway
univers
control
prrsv
cell
cultur
investig
role
play
viru
replic
investig
cell
use
pathway
inhibitor
cell
first
treat
mock
treat
inhibitor
solvent
respect
infect
viru
treatment
cell
significantli
inhibit
viru
replic
p
titer
reduc
h
pi
respect
fig
unexpectedli
virusinduc
activ
pathway
essenti
product
infecti
prrsv
progeni
viru
cytopath
effect
cpe
cell
character
cell
congreg
contract
interestingli
infect
cell
treat
cpe
significantli
allevi
normal
condit
prrsvinfect
cell
show
consider
cpe
h
pi
fig
b
cpe
observ
cell
use
treat
cell
fig
addit
inhibitor
concentr
could
induc
cpe
appar
cytotox
cell
fig
c
confirm
mtt
assay
data
shown
thu
find
suggest
pathway
may
link
hpprrsvinduc
cpe
format
cell
mani
virus
interfer
signal
pathway
infect
host
cell
favor
product
infect
also
impact
physiolog
host
cell
well
pathogenesi
therefor
identif
cellular
factor
involv
viru
replic
import
design
novel
antivir
strategi
regard
manipul
cellular
pathway
regul
cell
apoptosi
surviv
afford
great
advantag
viru
replic
mani
virus
demonstr
regul
cell
surviv
via
regul
pathway
previou
report
indic
pathway
activ
earli
phase
subsequ
inhibit
h
pi
prrsv
infect
modc
hpprrsv
strain
use
investig
pathway
control
viru
report
activ
pathway
significantli
enhanc
viru
earli
late
stage
infect
cell
distinct
pattern
adopt
infect
pam
phosphoryl
akt
occur
exclus
earli
stage
earli
min
pi
return
basal
level
min
pi
fig
cell
expos
uvirradiationinactiv
viru
significantli
increas
phosphoryl
akt
observ
pam
cell
entri
macrophag
prrsv
occur
via
similar
also
differ
mechan
compar
entri
cell
could
infer
viru
entri
process
pam
enough
activ
pathway
differ
mechan
activ
use
cell
possibl
differ
entri
mechan
result
differ
regul
akt
togeth
previou
data
report
zhang
et
al
gener
prrsv
regul
pathway
differ
mechan
modc
pam
cell
variou
proapoptot
protein
identifi
downstream
target
akt
includ
famili
member
bad
mtor
transcript
factor
famili
member
fkhr
normal
regul
manner
exampl
phosphoryl
bad
decreas
phosphoryl
mtor
increas
infect
varicellazost
viru
similarli
shown
cascad
contribut
establish
persist
hcv
infect
present
studi
demonstr
bad
regul
prrsv
control
pathway
late
stage
infect
cell
fig
therefor
cascad
may
manipul
prrsv
control
hostcel
surviv
pathway
shown
play
import
role
differ
step
life
cycl
varieti
virus
exampl
pathway
shown
involv
regul
ebola
viru
entri
host
cell
contribut
arenaviru
bud
involv
control
synthesi
viral
rna
nonseg
negativestrand
rna
virus
unexpectedli
investig
inhibitor
show
pathway
neglig
effect
titer
infecti
prrsv
progeni
cell
p
determin
h
pi
fig
inhibit
pathway
significantli
block
virusinduc
cpe
format
knowledg
similar
result
document
virus
therefor
worthwhil
futur
investig
pathway
regul
cpe
format
prrsv
infect
summari
find
togeth
previou
report
prrsv
regul
akt
modc
suggest
signal
modul
prrsv
differ
way
differ
cell
type
bad
employ
viru
downstream
target
pathway
unlik
virus
control
pathway
contribut
significantli
viru
replic
prrsv
import
gener
infecti
progeni
modul
chang
physiolog
host
cell
reveal
signific
allevi
cpe
find
may
offer
new
import
insight
role
viru
infect
even
viral
pathogenesi
